Boryung Corporation (KRX:003850)

Market Cap	781.44B
Revenue (ttm)	1.03T
Net Income (ttm)	56.45B
Shares Out	84.48M
EPS (ttm)	688.80
PE Ratio	13.43
Forward PE	21.03
Dividend	100.00 (1.10%)
Ex-Dividend Date	Dec 29, 2025

Volume	216,222
Average Volume	235,612
Open	9,100.00
Previous Close	9,080.00
Day's Range	9,100.00 - 9,370.00
52-Week Range	7,680.00 - 10,910.00
Beta	0.30
RSI	59.44
Earnings Date	Jan 28, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.